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ABSTRACT 
Further studies of the induction of the liver microsomal drug-hydroxylating enzyme system 
by prctreatment of rats with various drugs are presented. The phenobarbitaMnduccd in- 
crease in the microsomal content of CO-binding pigment and in the activities of TPNH- 
cytochrome c reductasc and the oxidative demethylation of aminopyrine is  proportional, 
within certain limits, to  the  amount of phenobarbital injected. Removal of the  inducer 
results in a  parallel decrease in the levels  of CO-binding pigment, TPNH-cytochrome c 
reductase,  and  aminopyrine demethylation.  Other  inducing drugs  have  been  investi- 
gated  and shown to  act similarly to  phenobarbital. The early increase in these enzymes 
is  found  in  the  microsomal  subfraction consisting of  rough-surfaced vesicles,  whereas 
repeated administration of the inducing drug results in a concentration of the enzymes in 
the  smooth-surfaced  vesicles.  The  phenobarbital-stimulated formation  of  cndoplasmic 
membranes is reflected in increased amounts of the various microsomal phospholipid frac- 
tions as revealed by thin layer chromatography. There is no significant difference between 
the stimulated rates of Pi  32 incorporation into phospholipids of the two different microsomal 
subfractions in response to phenobarbital treatment. The drug-induced enzyme synthesis 
is unaffected by adrcnalectomy. 
INTRODUCTION 
In previous papers  (l, 2)  it has been shown that 
the well recognized stimulation of the liver micro- 
somal drug-metabolizing activity by treatment of 
rats with phenobarbital (3-5)  is accompanied by 
an increase in the TPNH1--cytochrome c reductase 
activity and the content of CO-binding  pigment of 
the microsomes.  These findings suggested  that the 
TPNH-cytochrome c reductase and the CO-bind- 
ing pigment are components of the oxidative drug- 
metabolizing  enzyme  system,  a  conclusion also 
supported by biochemical evidence (6,  7).  Puro- 
1 Triphosphopyridine nucleotidc, reduced form. 
mycin and actinomycin D, which had been shown 
to inhibit the induction of stimulated drug metab- 
olism (8, 9),  abolished the increase in the levels of 
TPNH-cytochrome c reductase  and  CO-binding 
pigment ( l, 2), indicating the involvement  of a net 
synthesis of both enzymes which was preceded by 
the synthesis of messenger-RNA. Electron micros- 
copy revealed  (2)  a  marked  proliferation of the 
smooth-surfaced endoplasmic membranes, in ac- 
cordance  with  earlier  findings of  Remmer  and 
Merker (10), and there was an increase in micro- 
somal lipid which was reflected  in an enhanced 
725 incorporation of Pl  a2 into the microsomal phospho- 
lipids in vivo (2). The increase in drug-metabolizing 
activity appeared to be greater in the smooth than 
in the rough vesicle fraction of the microsomes (2, 
I0), 
Results of further studies of the induction of the 
liver microsomal drug-hydroxylating enzyme sys- 
tem are reported in the present paper. The kinetics 
of the enzyme induction caused by phenobarbital 
administration  has  been  studied.  The  effects  of 
other inducing drugs  upon  the  levels of TPNH- 
cytochrome c reductase  and CO-binding pigment 
have also been investigated. Furthermore, the early 
effects of phenobarbital on the pattern of distribu- 
tion  of  the  drug-hydroxylating  enzymes  between 
the  two  microsomal subfractions and on the pro- 
duction of various microsomal phospholipids have 
been studied. 
MATERIALS  AND  METHODS 
In  all  experiments  male  Sprague-Dawley  rats  (200 
to  300  gm)  were  used.  The  animals  were  starvcd 
overnight. Preparation of liver microsomes was pcr- 
formed  as  described by  Ernstcr et al.  (ll).  Rough- 
and smooth-surfaced vesicles were separated by den- 
sity  gradient  centrifugation in  the  presence  of Cs  + 
(12). 
The experimental animals received one daily in- 
injection intraperitoneally of  100  mg phenobarbital 
per  kg  body  weight,  unless  otherwise  stated.  The 
controls were given the same amount of 0.9 per cent 
NaC1.  In one series of experiments the effects of in 
vivo  treatment  with  other  known  inducing  agents 
were tested.  These were  anainopyrine  (4),  3-methyl- 
cholanthrene  (13),  and  nikethamide  (5);  the  doses 
were  150,  25,  and  250  mg  per  kg  body  weight, 
respectively.  These  drugs  also  were  injected  intra- 
peritoneally,  once  daily.  Aminopyrine  was  admin- 
istered in 0.9 per cent NaC1 solution, and 3-methyl- 
cholanthrene in  an appropriate  amount of corn oil. 
Control rats were  injected with either 0.9  per cent 
NaC1 or corn oil. 
Adrenalectomy was  performed  under  ether  anes- 
thesia.  Besides a  standard  diet  and  drinking water, 
the adrenalectomized rats were given a  0.9 per cent 
l'qaC1 solution ad libitum.  Treatment of these animals 
with  phenobarbital  (100  mg  per  kg  body  weight) 
was started 5 days after the operation. 
Protein was measured by the method of Lowry et 
al.  (14).  RNA was determined according to Ceriotti 
(15). The total microsomal lipids were extracted with 
a  chloroform-methanol mixture, and the extract was 
washed with 0.73 per cent NaCI (16). The amount of 
phosphorus was  determined  in  the perchloric acid- 
digested extract  (17). 
The  various  microsomal  phospholipid  fractions 
were separated by thin layer chromatography. Plates 
were  prepared  by  standard  technique  (18)  using 
Silica Gel G  (Merck)  as  adsorbent. After extraction 
of  the  microsomes  with  chloroform-methanol  and 
washing of the extract with 0.73  per cent NaC1,  as 
described  above,  the  chloroform-methanol  mixture 
was  evaporated.  The samples were put on the plate 
in a  minimal amount of chloroform-methanol (1 : 1). 
Chloroform-methanol-water  (100:40:6)  was used  as 
solvent to  develop  the  chromatograms,  which  were 
then  exposed  to  iodine  vapors  to  make  the  spots 
evident.  Purified samples of phospholipids,  obtained 
commercially,  were  run  parallel.  The  phosphorus 
content  of  the  various  spots  was  determined  (17). 
When the rate of Pt  32 incorporation into microsomal 
phospholipid was investigated,  1 me of Pi 3s was ad- 
ministered  intraperitoneally  1  hour  before  the  rats 
were killed. 
Oxidative  demethylation  activity  was  assayed 
with  aminopyrine  as  substrate  (7).  Other  enzyme 
assays were performed  as described by Dallner  (12). 
All chemicals employed were standard commercial 
products. 
RESULTS 
Kinetics of Induction 
Daily injections of phenobarbital in an amount 
of 100 mg per kg body weight for 5 days caused a 
ca.  5-fold enhancement of the activity of oxidative 
demethylation of aminopyrine in the liver micro- 
somes  (Fig.  1).  This increase was reached  after 5 
injections,  and  further  treatment  did  not  elevate 
the activity above this value.  When the dose was 
lowered,  a  less rapid  increase in  activity was ob- 
served.  However,  it was possible to reach a  ca.  5- 
fold  increase  over  controls  by  daily  injections  of 
66 mg of phenobarbital per kg body weight, if the 
treatment was continued for another 5-day period. 
With the lowest dose tested,  33 mg of phenobarbi- 
tal per kg body weight, a  3 to 4-fold enhancement 
in  activity  was  reached  after  15  daily  injections. 
Doses of phenobarbital higher than 100 mg per kg 
body weight did not cause  a  more rapid increase 
than did  I00 rag.  For each dose tested,  there was 
an increase in the amount of CO-binding pigment, 
as calculated on the protein basis, and in the spec- 
ific  activity  of  TPNH~cytochrome  c  reductase, 
parallel  to  the enhancement of the specific activ- 
ity of anainopyrine demethylation. Cessation of the 
phenobarbital treatment after 5  days resulted in a 
symmetric and parallel decrease in the levels, and 
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same as those for the control rats (Fig.  2). 
Effects of Various Inducing Drugs 
It has been shown (2)  that the phenobarbital- 
induced increase in the levels of the TPNH-cyto- 
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FIGURE 1  Enhanced rate of aminopyrine demethyla- 
tion after treatment of rats  with different daily doses 
of  penobarbital.  Triangles,  100  mg/kg body  weight; 
squares,  66  mg/kg  body  weight;  circles, 33  mg/kg 
body weight. Each value plotted represents an average 
of the specific activities of 4 experimental animals as 
compared with those of 4 control rats. The arrows indi- 
cate phenobarbital  injections. 
chrome c reductase and the CO-binding pigment 
is paralleled by a  similar enhancement of the in 
vitro rates of N-demethylation of aminopyrine and 
dimethylnitrosamine,  O-demethylation  of codeine, 
and  hydroxylation of  phenobarbital.  It  is  also 
accompanied by increased activities of side chain 
oxidation of hexobarbital and sulfoxide  formation 
from chlorpromazine (19).  If the  phenobarbital- 
induced enhancement of the metabolism of these 
different  drugs  is  directly  dependent  on  the 
stimulation of the  synthesis of the  hydroxylating 
system,  i.e. the  TPNH-cytochrome  c  reductase 
and the  CO-binding pigment, it seems  probable 
that other drugs, which are able to act as inducers 
of enhanced drug metabolism, also should act by 
causing increased levels of these  enzymes. Fig.  3 
shows that this was the case  for the drugs tested 
here.  Aminopyrine,  3-methylcholanthrene,  and 
nikethamide all caused a  parallel increase in the 
content of CO-binding pigment and in the activ- 
ities of TPNH-cytochrome c reductase and oxida- 
tive  demethylation.  As  with  phenobarbital,  the 
stimulating effects were limited to the parameters 
mentioned, whereas  the  levels of other enzymes, 
as  exemplified  in  Fig.  3  by  cytochrome  bs,  re- 
vealed no appreciable changes. 
Phospholipids 
It was found previously (9)  that  treatment of 
rats with phenobarbital caused a greatly enhanced 
incorporation in  vivo of Pi  32  into the  microsomal 
phospholipid, whereas the incorporation into the 
phospholipid  of  mitochondria was  only slightly 
increased.  Since  phospholipid  composition  is 
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FIGURE 2  Decrease  of enzyme activities 
after  cessation  of  phenobarbital  treat- 
ment. Each value plotted is an average of 
6 experiments. The injections (each 100 
mg/kg body weight) are indicated by the 
arrows. Crosses, oxidative demethylation 
activity;  circles, CO-binding  pigment; 
triangles, TPNH-cytochrome  c reductase 
activity. 
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FIGURE 3  Induction of increased rates of aminopyrine demethylation and TPNIt~cytochrome c reductase 
and increased content of CO-binding pigment in liver microsomes by pretreatment of the rats in vivo with 
aminopyrine (B), 3-methylcholanthrene (C),  and nikethamide (D), in comparison with control rats (A). 
Pretreatment of the rats was performed as described in Materials and Methods. Three daily injections 
of each drug were given. The bars represent mean values from 5 experiments. FA, formaldehyde. 
known to differ between different biological mem- 
branes (20), it seemed to be of interest to study the 
influence of phenobarbital  treatment  on the liver 
microsomal  phospholipids  in  greater  detail.  This 
was  done  by determining  individual  components 
of the phospholipid  fraction  at different intervals 
after phenobarbital  treatment,  and  also by meas- 
uring  their  specific  radioactivity  following injec- 
tion of Pi  32 into the rats.  Most of the phospholipid 
was found to be in the form of phosphafidylcholine, 
whereas  sphingomyelin,  phosphatidylethanola- 
mine,  and  phosphatidylinositol  were  minor  com- 
ponents  2  (Fig.  4).  These  data  are  in  agreement 
with  those  reported  elsewhere  (21).  As shown  in 
Table I,  12 hours after a single injection of pheno- 
2 This method did not provide a  separation of phos- 
phatidylserine,  which was probably recovered in the 
phosphatidylcholine fraction (18). 
barbital there was a more than  1.5-fold increase in 
the  total  microsomal  lipid  phosphorus  and  a  ca. 
2.5-fold enhancement of the specific activity. Most 
of this increase was due to the phosphatidylcholine 
fraction.  Repeated  phenobarbital  injections gave 
rise to  a  further  increase in the various phospho- 
lipid fractions  (Fig.  4). 
A drenalectomy 
Thyroidectomy  has  previously been  shown  (2) 
not to influence the phenobarbital-induced  activ- 
ation  of  the  drug-hydroxylating  enzyme  system. 
In  Table  II  it  is shown  that  the  same  holds for 
adrenalectomized  animals.  These  results  are  in 
line with  the  observation of Kato et al.  (22)  that 
adrenalectomy  did  not  affect  the  drug-induced 
activation  of microsomal  strychnine  metabolism, 
and with the results of Conney et al. (23) from stud- 
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FIGURE 4  Effect  of  phenobarbital treatment  on  the  content of  various  mierosomal phospholipids: 
sphingomyelin (A); phosphatidylcholine (B); phosphatidylethanolamine (C); phosphatidylinositol (D). 
The bars represent  mean values from 5 experiments. 
TABLE  I 
Stimulation of the Rate of p~2 Incorporation into Liver Microsomal Phospholipids by  Treatment of 
Rats with Phenobarbital 
The treated rats received one injection of 100 mg of phenobarbital per kg body weight 12 hours before 
they were killed. The controls received the same volume of 0.9 per cent NaC1.  The table  shows the 
mean values and standard deviations from 6 experiments. 
Control  Treated 
gg lipid P  ug lipid P 
Fraction  per gm liver  cpra per t*g lipid P  per gm liver  cP~t per tzg lipid P 
Total phospholipids  340  -4- 40  260  4-  48  560  4-4- 65  640  4-  120 
Sphingomyelin  50  -4-  12  185  4-  27  80  4-  19  350  4-  56 
Phosphatidylcholine  130  4-  22  250  4-  60  290  4-  38  775  4-  149 
Phosphatidylethanolamine  60  4-  10  300  4-  56  90  4-  16  500  4-  96 
Phosphatidylinositol  50  4-  11  200  4-  33  60  -4-  16  300  4-  49 
TABLE  II 
Phenobarbital-Induced Enzyme Synthesis in Adrenalectomized Rats 
Adrenalectomy and treatment of the rats with phenobarbital was performed as described in Materials 
and Methods. FA, formaldehyde. 
No,  of phenobarbital  TPNH-cytochrome ¢  Oxidative demethylation 
treatments  Protein  reduetase activity  CO-binding pigment  activity 
~moles TPNH 
mg/gm liver  ox./min./mg  protein  £xE4~o_sso/mg  protein  m~moles  FA/min./mg protein 
0  19.0  0.022  0.020  3.35 
1  20.1  0. 038  0.035  5.20 
2  22.0  0.061  0.056  7.70 
3  24.2  0.078  0.082  13.80 
ies  of the  induction  of enhanced  N-demethylase 
activity by 3-methylcholanthrene. 
Early Effects of Phenobarbital Stimulation 
Previous studies have  revealed  (I,  2)  that  the 
phenobarbital-induced  enhancement  of  the  hy- 
droxylation of various  drugs  is  paralleled  by  an 
increased  amount  of  endoplasmic  membranes. 
Morphologically there was mainly an increase in 
the  content of  smooth-surfaced endoplasmic  re- 
ticulum;  also the isolated smooth-surfaced vesicle 
fraction displayed a  greater enhancement of oxi- 
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FIGURE 6 
T  R  S 
T  R  S 
Control  Tre,  ted 
Increased rate of incorporation of  Pi  ~ into 
phospholipid of the total liver microsomal fraction and 
of isolated rough and smooth vesicle fractions 6 hours 
after one injection of 100 mg of phenobarbital  per kg 
body weight. Mean values of 4 experiments.  T, total 
liver microsomes; R, rough-surfaced vesicles; S, smooth- 
surfaced vesicles. 
dative  demethylation  activity  after  repeated 
injections  of  phenobarbital  than  did  the  rough- 
surfaced  vesicle  fraction.  In  order  to  study  the 
earliest  measurable  changes  in  the  levels of  the 
hydroxylating enzymes of the two microsomal sub- 
fractions,  experiments  were  performed  in  which 
the rats were killed 3,  6,  12,  and  24 hours  after a 
single  phenobarbital  injection.  The  liver  micro- 
somes were  divided  into  smooth-  and  rough-sur- 
faced vesicle fractions by density gradient centrif- 
ugation in the presence of Cs  +  (12).  As shown in 
Fig. 5 a, the total microsomal fraction exhibited a 
ca.  1.5-fold increase over controls in the amount of 
CO-binding  pigment and  the specific activities of 
TPNH-cytochrome  c reductase  and  aminopyrine 
demethylation  as  measured  6  hours  after  the  in- 
jection of phenobarbital.  This increase  continued 
and was about 2-fold 24 hours after the treatment. 
Comparison of the rough and smooth vesicle frac- 
tions (Fig. 5 b and c) reveals that the rough vesicle 
fraction almost exclusively accounts for the initial 
rise  of  the  enzymes,  observed  between  3  and  6 
hours,  after which the activation tends to level off 
in this fraction. Conversely, the increase in enzyme 
levels in  the  smooth  vesicle fraction  is  negligible 
after  6  hours,  hut  proceeds  then  at  a  progressive 
rate.  After 24 hours,  the enzyme levels are equal 
in the two fractions,  in  accordance with previous 
findings  (1,  2). 
The striking difference in enzyme levels between 
smooth-  and  rough-surfaced  vesicles at  the  early 
stages  of  enzyme  induction,  described  above, 
prompted  interest  in  comparing  the  rates  of in- 
corporation  of Pi  32 into phospholipids  in  vivo  into 
the  two  types  of  endoplasmic  membranes.  As 
shown in Fig.  6, both the rough- and smooth-sur- 
faced vesicle fractions revealed markedly enhanced 
rates  of Pi  ~2  incorporation  into  phospholipid  6 
hours  after  phenobarbital  treatment,  and  there 
was no significant difference between the two frac- 
tions. 3 
DISCUSSION 
From the data presented in this paper it is evident 
that  the  activity of the  TPNH-cytochrome  c  re- 
ductase  and  the  amount  of CO-binding  pigment 
Under the conditions  employed here,  i.e.  injection 
of Pi  32  1  hour  before  the  animals  were  killed,  the 
specific  radioactivity  of  the  total  liver  microsomal 
phospholipid  P in the phenobarbital-treated  animals 
was about  20 per cent of that of the liver or plasma 
Pi.  Isotopic  equilibrium  between  liver  microsomal 
phospholipid  P  and  the  liver  or  plasma  Pi  was 
reached  about  8  hours  after  the  intraperitoneal 
injection of P~e. 
FIGURE 5  Effect of one phenobarbital injection on the content of CO-binding pigment and 
on the activities of TI)NH-cytochrome c reductase and aminopyrine demethylation of the 
total microsomal fraction and of isolated rough and smooth vesicle fractions. The averages 
of the amount of CO-binding pigment per mg protein and of the specific activities of TPNH 
-cytochrome c  reductase  and  aminopyrine  demethylation  of the  phenobarbital-treated 
group (5 rats)  are plotted in relation to the corresponding values for the control group (5 
rats).  Triangles, TPNH-~cytochrome c reductase  activity; circles,  CO-binding pigment; 
squares, oxidative demethylation activity. The arrow indicates the phenobarbital injection. 
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the  over-all  drug-hydroxylating  activity,  during 
both the induction phase following drug adminis- 
tration, and the regression phase after its cessation. 
The  changes  of the  three  parameters  were  also 
parallel regardless of the absolute intensity of the 
induction, when the latter was varied by using dif- 
ferent  doses  of drug  or  different  drugs.  Besides 
once  more  emphasizing  the  involvement of  the 
TPNH-cytochrome c reductase and the CO-bind- 
ing  pigment  in  the  drug-hydroxylating  enzyme 
system--a conclusion already supported by several 
lines of evidence (2,  7)--these results suggest that 
the turnover of the two enzymes probably is reg- 
ulated by a  common mechanism.  Such a conclu- 
sion would be consistent with the concept of  Jacob 
and  Monod  (24)  that  the  genes  controlling  the 
single  enzymes in  a  metabolic  sequence may  be 
present in a cluster, called "operon,"  regulated by 
a common operator gene. That the drug-induced 
changes in enzyme levels observed here reflect net 
enzyme synthesis is very probable in view of the 
fact, reported earlier (2),  that the effects  are abol- 
ished by actinomycin D  and puromycin. 
Repeated  administration  of an  inducing  drug 
has previously been shown to cause an  accumula- 
tion  of smooth-surfaced  endoplasmic  membranes 
of the liver, highly active in drug metabolism (1, 
2).  The  present  studies  have  revealed  that  the 
rough vesicle fraction first exhibits increased levels 
of the induced enzymes. Similar observations have 
recently been reported by Dallner et al.  (25)  from 
studies  of the  postnatal  development of liver mi- 
crosomal  enzymes.  It is well established  that  the 
rough-surfaced and smooth-surfaced canals of the 
endoplasmic  reticulum  represent  a  continuous 
system (26,  27),  and there are indications that the 
two structures  can readily change from one form 
to  the  other  under  different conditions  (28,  29). 
It appears  conceivable, therefore,  that  the  newly 
formed enzyme protein is synthesized by and built 
into  the  rough-surfaced  membranes  of the  endo- 
plasmic  reticulum,  and  that  these  membranes, 
once "saturated"  with enzymes,  release the ribo- 
somes and accumulate as smooth-surfaced profiles. 
Electron micrographs suggestive of such a separa- 
tion  of ribosomes  from  endoplasmic  membranes 
have recently been obtained by Heuson-Stiennon 
(30)  in studies of myofilament synthesis  in embry- 
onic rat muscle. 
The existence of a large number of hydroxylases 
(i.e.  enzymes transferring the active hydroxylating 
radical to the drug), each one specific for one drug 
or a group of drugs, has repeatedly been postulated 
on  the  basis  of observed  species  differences  and 
stereospecificity of various hydroxylations (of.  31). 
However, the formation of an active hydroxylating 
radical  may in  itself be  sufficient to  bring  about 
hydroxylations,  without  the  intervention  of  any 
additional  enzyme, as  pointed out by Staudinger 
et al.  (32).  The concept of specific hydroxylating 
enzymes is not supported by the widely recognized 
fact, also revealed by the present work, that a wide 
variety of drugs can induce an  enhanced metab- 
olism of another  wide  variety of drugs. 4 Admit- 
tedly, it may be assumed that the specific hydroxyl- 
ases  are not rate-limiting for the over-all process, 
and that an elevation of the TPNH-cytochrome c 
reductase  and  CO-binding pigment levels, as  in- 
duced by any given drug, may enhance the metab- 
olism of a  number of other drugs  as  well.  It ap- 
pears equally possible,  however, that the apparent 
preference of the hydroxylating system for one or 
another  drug  may  be  explained  in  terms  of dif- 
ferent  accessibilities  of  the  different  drugs  to  a 
common  enzymic  site  in  the  microsomal  mem- 
brane structure (cf.  32,  33).  Studies of the binding 
of drugs to microsomes may be helpful in deciding 
this question. Such investigations are now in prog- 
ress in this laboratory. 
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4 How generally this  statement  holds cannot  be  de- 
cided  on  the  basis of the  information  available.  It 
has been reported, for example,  that the metabolism 
of only  certain foreign  compounds,  such  as  benzpy- 
rene,  acetanilid,  and  3-methyl-4-monomethylamino- 
azobenzene,  was  markedly  enhanced  by  treatment 
with polyeyelic  hydrocarbons,  whereas  the  metabo- 
lism of other drugs,  such  as  aminopyrine and hexo- 
barbital, was not influenced  (4, 34), and furthermore 
that  TPNH-cytochrome c  reductase  is  not  appre- 
ciably  enhanced  after  one  injection  of  3-methyl- 
cholanthrene (35). 
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